Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in hospitalized infants under six months of age with respiratory syncytial virus.

Respiratory Syncytial Virus ... spikes are in the news, the virus is actually just as worrisome in older adults. In fact, while more than 2 million children under age 5 make an RSV-related ...

As we enter the hot summer months, human behavior patterns, along with other mutating viruses, create the perfect recipe for ...

New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab ... for otherwise healthy infants under one year of age. The 3,600-subject MK-1654-004 ...

Medicare now covers the RSV vaccine for older adults under Part D, which typically covers prescription drugs. This means you shouldn’t incur any out-of-pocket costs. Respiratory syncytial virus ...

Last year people aged between 75 and 79 and pregnant women were offered a first-of-its-kind jab against respiratory syncytial virus (RSV ... around 30,000 children under five years old and ...

Find Virus Under Microscope stock video, 4K footage, and other HD footage from iStock. Get higher quality Virus Under Microscope content, for less—All of our 4K video clips are the same price as HD.